Markets.com Logo
markets.com

DRUG

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    43.6438$
  • Previous Close
    41.8875$
  • 52 Week Change
    78.08$
  • Day Range
    1.76$
  • 52 Week High/Low
    0.94$ - 79.02$
  • Dividend Per Share
    --
  • Market cap
    305 M$
  • EPS
    -0.74
  • Beta
    0.17
  • Volume
    --

About

The stock symbol DRUG.US refers to a tracker of companies involved in the development, production, and sales of pharmaceutical products. It is generally associated with an Exchange Traded Fund (ETF) that invests in a basket of stocks within the pharmaceutical or drug industry, providing investors with diversified exposure to this sector.
markets.com
Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Julian Parker|--
Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Julian Parker|--
Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Julian Parker|--
Cryptos shine again, USD on the edge

Cryptos shine again, USD on the edge

Darius Anucauskas|--
Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Julian Parker|--
Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Julian Parker|--
Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Daniel Carter|--

Factors

Drug approval progress and potential setbacks significantly influence investor confidence. Positive clinical trial results typically boost prices.

Regulatory decisions by agencies like the FDA can cause dramatic price swings. Approval or rejection of key drugs heavily impacts valuation.

Competition from other pharmaceutical companies developing similar therapies affects market share projections and profitability, thus the stock price.

Overall market conditions and economic indicators can impact investor sentiment toward the entire pharmaceutical sector, including DRUG.US.

Company financial performance, including revenue, earnings, and pipeline strength, are crucial drivers of investor perception and valuation.

People Also Watch

Latest news

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

Julian Parker|--
Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Julian Parker|--
SK Hynix Stock Drops 5% as Workers Reject Pay Deal

SK Hynix Stock Drops 5% as Workers Reject Pay Deal

Julian Parker|--

Latest Education Articles

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

Daniel Carter|--
How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

Daniel Carter|--
How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

Daniel Carter|--
Recommended Topics
markets.com